2021 CNS Research Day

**As a result of COVID-19 and the increased need to practice social distancing, our Research Committee has decided that this event will be entirely virtual**

On April 13, 2021, the Department of Clinical Neurological Sciences will be hosting its 18th annual CNS Research Day. The half day-long event features a series of poster and oral presentations from our residents, graduate students, PhD candidates and postdoctoral fellows. We will also host a distinguished researcher who will present the keynote address. Attendees of the event are the Department’s faculty, including neurosurgeons, neurologists, affiliated radiologists, pathologists and imaging researchers.

Research Day will be held on a program called Whova. If you would like to register for the event, please do so here. By creating an account using the same email you used to register, and creating a password, you can log into the event on the website here. Whova can be accessed on any desktop or mobile device. Instructions on how to do this can be found here.

Schedule of Events

CNS Research Day will run from 8:00 a.m. to 1:30 p.m.

Click here to view the timing of events.

Keynote Speaker

Dr. Michelle PloughmanDr-Michelle-Ploughman-2020.jpg
Dr. Ploughman is Associate professor of Medicine at Memorial University, St. John’s NL and Canada Research Chair in Neuroplasticity, Neurorehabilitation and Brain Recovery. She is a physiotherapist, a neuroscientist and a recognized expert in neuroplasticity and neurorehabilitation in stroke and multiple sclerosis. Her research focuses on the effects of aerobic exercise, intensive training paradigms and lifestyle habits on the brain challenged by injury, disease and aging. Her work is published in journals such as Stroke, Neuroscience, Brain Research and Archives of Physical Medicine and Rehabilitation.



Important Deadlines

Feb 2nd Abstract submissions open
March 2nd Abstract submissions close
March 9th Abstract submissions distributed to RC for scoring
March 16th Research Committee selects abstracts for oral presentations, posters
March 17-18th Notification to presenters of oral/poster acceptance
March 30th Research Committee reviews final program, award plans poster presenters begin recording presentations.
April 5th Recorded poster presentations due.
April 9th Judges/participants can begin reviewing pre-recorded posters, posting questions
April 13th Research Day (Virtual WHOVA Platform). 

Abstract Submission Guidelines

Submit Abstracts Here

Eligibility Requirements
Must have an author or contributor who holds a membership in CNS.
Abstracts should be no longer than 350 words and utilize the headings described below.

Basic Information
Abstract Title, First Author, Additional Author(s) and Research Supervisor

Abstract Submission Criteria/Format
*based on the JAMA Structure for Abstract Submission


The abstract should begin with a maximum of two sentences explaining the clinical (or other) importance of the study question.


State the precise objective or study question addressed in the report (e.g. "To determine whether..."). If more than 1 objective is addressed, the main objective should be indicated and only key secondary objectives stated. If a priori hypothesis was tested, it should be stated.

Design and Participants:

Describe the basic design of the study and include the specific study type (e.g. randomized clinical trial, cohort, cross-sectional, etc.) and intervention where applicable. State the clinical disorders, important eligibility criteria, and key socio-demographic features of patients (or other study participants). The number of eligible participants and how they were selected should be provided, including the number approached but who refused or were excluded. For selection procedures, these terms should be used, if appropriate: random sample (where random refers to a formal, randomized selection in which all eligible individuals have a fixed and usually equal chance of selection); population-based sample; referred sample; consecutive sample; volunteer sample; convenience sample. If matching is used for comparison groups, characteristics that are matched should be specified. In follow-up studies, the proportion of participants who completed the study must be indicated.


Summary demographic information (e.g. characteristics such as sex and age) and the number of study participants should be reported in the first sentence of the Results paragraph. The main outcomes of the study should be reported and quantified, including the final included/analyzed sample. When possible, present numerical results (e.g. absolute numbers and/or rates) with appropriate indicators of uncertainty, such as confidence intervals. Use means and standard deviations (SDs) for normally distributed data and medians and ranges or interquartile ranges (IQRs) for data that are not normally distributed. Avoid solely reporting the results of statistical hypothesis testing, such as P values, which fail to convey important quantitative information. For most studies, P values should follow the reporting of comparisons of absolute numbers or rates and measures of uncertainty (e.g. 0.8%, 95% CI −0.2% to 1.8%; P = .13). 

Conclusions and Relevance:

Provide only conclusions of the study that are directly supported by the results. Give equal emphasis to positive and negative findings of equal scientific merit. Also, provide a statement of relevance indicating implications for clinical practice or health policy, avoiding speculation and overgeneralization. The relevance statement may also indicate whether additional study is required before the information should be used in clinical settings.

Click here to download this information as a PDF.


Poster Printing Services:

Poster printing will not be necessary this year as this event is virtual. Please ensure your poster is made available in PDF format. Instructions on where to upload your poster and presentation will be communicated in advance.

Abstract Writing Tips & Tricks:

Event Sponsors

Award Winners

The 2021 CNS Research Day Award Winners are:

Top Oral Presentation:

Simon Benoit, Graduate Student, “Towards a machine-learning based classifier for the diagnosis of Parkinson’s disease”

Top Three Pre-Recorded Poster Sessions:

Erin Iredale, PhD Candidate, “Multi-Electrode Treatment Planning System for Intratumoral Modulation Therapy”
Mila Uzelac, Graduate Student, “Investigating the Effect of Intratumoral Modulation Therapy on Patient-Derived Breast Cancer Brain Metastases”
Nasim Mortazavi, PhD Candidate, “Discriminating sharp-wave ripples and interictal epileptiform discharges in patients with mesial temporal epilepsy using intracranial EEG recordings”